Vaccination against helminth parasite infections

References

• Hotez PJ, Brindley PJ, Bethony JM, et al. Helminth infections: the great neglected tropical diseases. J Clin Invest 2008;118:1311-21
   PubMed Web of Science ®Google Scholar
• Maizels RM, Holland M, Falcone FH, et al. Vaccination against helminth parasites : the ultimate challenge for immunologists? Immunol Rev 1999;171:125-48
   PubMed Web of Science ®Google Scholar
• Bethony JM, Cole RN, Guo X, et al. Vaccines to combat the neglected tropical diseases. Immunol Rev 2011;239:237-70
   PubMed Web of Science ®Google Scholar
• Allen JE, Maizels RM. Diversity and dialogue in immunity to helminths. Nat Rev Immunol 2011;11:375-88
   PubMed Web of Science ®Google Scholar
• Anthony RM, Rutitzky LI, Urban JF Jr, et al. Protective immune mechanisms in helminth infection. Nat Rev Immunol 2007;7:975-87
   PubMed Web of Science ®Google Scholar
• Maizels RM, Hewitson JP, Smith KA. Susceptibility and immunity to helminth parasites. Curr Opin Immunol 2012;24(4):459-66
   PubMedGoogle Scholar
• Hagan P, Blumenthal UJ, Dunn D, et al. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-5
   PubMed Web of Science ®Google Scholar
• Jackson JA, Turner JD, Rentoul L, et al. T helper cell type 2 responsiveness predicts future susceptibility to gastrointestinal nematodes in humans. J Infect Dis 2004;190:1804-11
   PubMed Web of Science ®Google Scholar
• Turner JD, Jackson JA, Faulkner H, et al. Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness. J Infect Dis 2008;197:1204-12
   PubMed Web of Science ®Google Scholar
• Watanabe K, Mwinzi PN, Black CL, et al. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg 2007;77:676-82
   PubMedGoogle Scholar
• Metenou S, Dembele B, Konate S, et al. Filarial infection suppresses malaria-specific multifunctional Th1 and th17 responses in malaria and filarial coinfections. J Immunol 2011;186:4725-33
   PubMed Web of Science ®Google Scholar
• Wammes LJ, Hamid F, Wiria AE, et al. Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics. PLoS Negl Trop Dis 2012;6:e1655
   PubMedGoogle Scholar
• Daniłowicz-Luebert E, O’Regan NL, Steinfelder S, Hartmann S. Modulation of specific and allergy-related immune responses by helminths. J Biomed Biotechnol 2011;2011:821578
   PubMedGoogle Scholar
• McSorley HJ, Hewitson JP, Maizels RM. Immunomodulation by helminth parasites: defining mechanisms and mediators. Int J Parasitol 2013;43:301-10
   PubMed Web of Science ®Google Scholar
• Jia TW, Melville S, Utzinger J, et al. Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis. PLoS Negl Trop Dis 2012;6:e1621
   PubMed Web of Science ®Google Scholar
• Mutapi F, Billingsley PF, Secor WE. Infection and treatment immunizations for successful parasite vaccines. Trends Parasitol 2013;29:135-41
   PubMed Web of Science ®Google Scholar
• Prichard RK, Basanez MG, Boatin BA, et al. A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 2012;6:e1549
   PubMed Web of Science ®Google Scholar
• Bergquist R, Lustigman S. Control of important helminthic infections vaccine development as part of the solution. Adv Parasitol 2010;73:297-326
   PubMed Web of Science ®Google Scholar
• van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007;212:475-90
   PubMed Web of Science ®Google Scholar
• Bain RK. Irradiated vaccines for helminth control in livestock. Int J Parasitol 1999;29:185-91
   PubMedGoogle Scholar
• Miller TA. Vaccination against the canine hookworm diseases. Adv Parasitol 1971;9:153-83
   PubMedGoogle Scholar
• Loukas A, Good MF. Back to the future for antiparasite vaccines? Expert Rev Vaccines 2013;12:1-4
   PubMed Web of Science ®Google Scholar
• Campbell CH. The antigenic role of the excretions and secretions of Trichinella spiralis in the production of immunity in mice. J Parasitol 1955;41:483-91
   PubMed Web of Science ®Google Scholar
• Pearson MS, Ranjit N, Loukas A. Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites. Biol Chem 2010;391:901-11
   PubMedGoogle Scholar
• Munn EA. Rational design of nematode vaccines: hidden antigens. Int J Parasitol 1997;27:359-66
   PubMedGoogle Scholar
• Knox DP, Redmond DL, Newlands GF, et al. The nature and prospects for gut membrane proteins as vaccine candidates for Haemonchus contortus and other ruminant trichostrongyloids. Int J Parasitol 2003;33:1129-37
   PubMedGoogle Scholar
• Hagan P, Behnke JM, Parish HA. Stimulation of immunity to Nematospiroides dubius in mice using larvae attenuated by cobalt 60 irradiation. Parasite Immunol 1981;3:149-56
   PubMedGoogle Scholar
• Hewitson JP, Harcus Y, Murray J, et al. Proteomic analysis of secretory products from the model gastrointestinal nematode Heligmosomoides polygyrus reveals dominance of Venom Allergen-Like (VAL) proteins. J Proteomics 2011;74:1573-94
   PubMed Web of Science ®Google Scholar
• Hewitson JP, Ivens AC, Harcus Y, et al. Secretion of protective antigens by tissue-stage nematode larvae revealed by proteomic analysis and vaccination-induced sterile immunity. PLOS Pathog 2013;9:e1003492
   PubMedGoogle Scholar
• Wakelin D, Selby GR. Functional antigens of Trichuris muris. The stimulation of immunity by vaccination of mice with somatic antigen preparations. Int J Parasitol 1973;3:711-15
   PubMedGoogle Scholar
• Dixon H, Little MC, Else KJ. Characterisation of the protective immune response following subcutaneous vaccination of susceptible mice against Trichuris muris. Int J Parasitol 2010;40:683-93
   PubMed Web of Science ®Google Scholar
• Silberstein DS, Despommier DD. Antigens from Trichinella spiralis that induce a protective response in the mouse. J Immunol 1984;132:898-904
   PubMed Web of Science ®Google Scholar
• Gamble HR. Trichinella spiralis: immunization of mice using monoclonal antibody affinity-isolated antigens. Exp Parasitol 1985;59:398-404
   PubMedGoogle Scholar
• Grencis RK, Crawford CR, Pritchard DI, et al. Immunization of mice with surface antigens from the muscle larvae of Trichinella spiralis. Parasite Immunol 1986;8:587-96
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang Z, Yang J, et al. Oral vaccination with Ts87 DNA vaccine delivered by attenuated Salmonella typhimurium elicits a protective immune response against Trichinella spiralis larval challenge. Vaccine 2010;28:2735-42
   PubMed Web of Science ®Google Scholar
• Pompa-Mera EN, Yépez-Mulia L, Ocaña-Mondragón A, et al. Trichinella spiralis: intranasal immunization with attenuated Salmonella enterica carrying a gp43 antigen-derived 30 mer epitope elicits protection in BALB/c mice. Exp Parasitol 2011;129:393-401
   PubMedGoogle Scholar
• Harvie M, Camberis M, Tang SC, et al. The lung is an important site for priming CD4 T-cell-mediated protective immunity against gastrointestinal helminth parasites. Infect Immun 2010;78:3753-62
   PubMedGoogle Scholar
• Nouir NB, Eschbach M-L, Piédavent M, et al. Vaccination with Strongyloides ratti heat shock protein 60 increases susceptibility to challenge infection by induction of Th1 response. Vaccine 2012;30:862-71
   PubMed Web of Science ®Google Scholar
• Abraham D, Hess JA, Mejia R, et al. Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice. Vaccine 2011;29:8134-40
   PubMed Web of Science ®Google Scholar
• Loukas A, Bethony J, Brooker S, Hotez P. Hookworm vaccines: past, present, and future. Lancet Infect Dis 2006;6:733-41
   PubMed Web of Science ®Google Scholar
• Loukas A, Bethony JM, Williamson AL, et al. Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms. J Infect Dis 2004;189:1952-61
   PubMedGoogle Scholar
• Bethony J, Loukas A, Smout M, et al. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. Faseb J 2005;19:1743-5
   PubMed Web of Science ®Google Scholar
• Loukas A, Bethony JM, Mendez S, et al. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med 2005;2:e295
   PubMed Web of Science ®Google Scholar
• Xiao S, Zhan B, Xue J, et al. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus. Exp Parasitol 2008;118:32-40
   PubMed Web of Science ®Google Scholar
• Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME. New vaccines for neglected parasitic diseases and dengue. Transl Res 2013;162:144-55
   PubMed Web of Science ®Google Scholar
• Diemert DJ, Pinto AG, Freire J, et al. Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths. J Allergy Clin Immunol 2012;130:169-76. e166
   PubMed Web of Science ®Google Scholar
• Zhan B, Santiago H, Keegan B, et al. Fusion of Na-ASP-2 with human immunoglobulin Fcgamma abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE. Parasite Immunol 2012;34:404-11
   PubMedGoogle Scholar
• Hotez PJ, Diemert D, Bacon KM, et al. The Human Hookworm Vaccine. Vaccine 2013;31(Suppl 2):B227-32
   PubMed Web of Science ®Google Scholar
• Ranjit N, Zhan B, Hamilton B, et al. Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus. J Infect Dis 2009;199:904-12
   PubMed Web of Science ®Google Scholar
• Pearson MS, Bethony JM, Pickering DA, et al. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J 2009;23:3007-19
   PubMedGoogle Scholar
• Zhan B, Liu S, Perally S, et al. Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum. Infect Immun 2005;73:6903-11
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Bethony JM, Diemert DJ, et al. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol 2010;8:814-26
   PubMedGoogle Scholar
• Fujiwara RT, Zhan B, Mendez S, et al. Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clin Vaccine Immunol 2007;14:281-7
   PubMedGoogle Scholar
• Morris CP, Evans H, Larsen SE, Mitre E. A comprehensive, model-based review of vaccine and repeat infection trials for filariasis. Clin Microbiol Rev 2013;26:381-421
   PubMed Web of Science ®Google Scholar
• Yates JA, Higashi GI. Brugia malayi : vaccination of jirds with 60Cobalt-attenuated infective stage larvae protects against homologous challenge. Am J Trop Med Hyg 1985;34:1132-7
   PubMed Web of Science ®Google Scholar
• Gregory WF, Atmadja AK, Allen JE, Maizels RM. The abundant larval transcript 1/2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infect Immun 2000;68:4174-9
   PubMed Web of Science ®Google Scholar
• Lustigman S, James ER, Tawe W, Abraham D. Towards a recombinant antigen vaccine against Onchocerca volvulus. Trends Parasitol 2002;18:135-41
   PubMed Web of Science ®Google Scholar
• Makepeace BL, Jensen SA, Laney SJ, et al. Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure. PLoS Negl Trop Dis 2009;3:e544
   PubMed Web of Science ®Google Scholar
• Babayan SA, Attout T, Harris A, et al. Vaccination against filarial nematodes with irradiated larvae provides long-term protection against the third larval stage but not against subsequent life cycle stages. Int J Parasitol 2006;36:903-14
   PubMed Web of Science ®Google Scholar
• Hübner MP, Torrero MN, Mitre E. Type 2 immune-inducing helminth vaccination maintains protective efficacy in the setting of repeated parasite exposures. Vaccine 2010;28:1746-57
   PubMedGoogle Scholar
• Torrero MN, Morris CP, Mitre BK, et al. Basophils help establish protective immunity induced by irradiated larval vaccination for filariasis. Vaccine 2013;31:3675-82
   PubMedGoogle Scholar
• Babayan S, Luo H, Gray N, et al. Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes. PLoS Negl Trop Dis 2012;6:e1968
   PubMed Web of Science ®Google Scholar
• Ziewer S, Hubner MP, Dubben B, et al. Immunization with L. sigmodontis microfilariae reduces peripheral microfilaraemia after challenge infection by inhibition of filarial embryogenesis. PLoS Negl Trop Dis 2012;6:e1558
   PubMedGoogle Scholar
• Zipperer GR, Arumugam S, Chirgwin SR, et al. Brugia pahangi: immunization with early L3 ES alters parasite migration, and reduces microfilaremia and lymphatic lesion formation in gerbils (Meriones unguiculatus). Exp Parasitol 2013;135:446-55
   PubMedGoogle Scholar
• Hewitson JP, Rückerl D, Harcus Y, et al. The secreted triose phosphate isomerase of Brugia malayi is required to sustain microfilaria production in vivo. PLoS Pathog 2014. In press
   PubMedGoogle Scholar
• McManus DP, Loukas A. Current status of vaccines for schistosomiasis. Clin Microbiol Rev 2008;21:225-42
   PubMed Web of Science ®Google Scholar
• Hewitson JP, Hamblin PA, Mountford AP. Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 2005;27:271-80
   PubMed Web of Science ®Google Scholar
• Eberl M, Langermans JAM, Frost PA, et al. Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun 2001;69:5352-62
   PubMed Web of Science ®Google Scholar
• Bickle QD. Radiation-attenuated schistosome vaccination--a brief historical perspective. Parasitology 2008;136:1621-32
   Google Scholar
• Wilson RA, Coulson PS. Schistosome vaccines: a critical appraisal. Mem Inst Oswaldo Cruz 2006;101(Suppl 1):13-20
   PubMedGoogle Scholar
• Bergquist NR, Colley DG. Schistosomiasis vaccines: research to development. Parasitol Today 1998;14:99-104
   PubMedGoogle Scholar
• Boulanger D, Warter A, Trottein F, et al. Vaccination of patas monkeys experimentally infected with Schistosoma haematobium using a recombinant glutathione S-transferase cloned from S.mansoni. Parasite Immunol 1995;17:361-9
   PubMedGoogle Scholar
• Capron A, Riveau G, Capron M, Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 2005;21:143-9
   PubMed Web of Science ®Google Scholar
• Riveau G, Deplanque D, Remoue F, et al. Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl Trop Dis 2012;6:e1704
   PubMed Web of Science ®Google Scholar
• Moser D, Tendler M, Griffiths G, Klinkert M-Q. A 14-kDA Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J Biol Chem 1991;266:8447-54
   PubMed Web of Science ®Google Scholar
• Tendler M, Simpson AJ. The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Acta Trop 2008;108:263-6
   PubMed Web of Science ®Google Scholar
• Tendler M, Brito CA, Vilar MM, et al. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Proc Natl Acad Sci USA 1996;93:269-73
   PubMed Web of Science ®Google Scholar
• Kupferschmidt K. A worm vaccine, coming at a snail’s pace. Science 2013;339:502-3
   PubMedGoogle Scholar
• Martins VP, Pinheiro CS, Figueiredo BC, et al. Vaccination with enzymatically cleaved GPI-anchored proteins from Schistosoma mansoni induces protection against challenge infection. Clin Dev Immunol 2012;2012:962538
   PubMedGoogle Scholar
• Sulbaran G, Noya O, Brito B, et al. Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigens. PLoS Negl Trop Dis 2013;7:e2254
   PubMedGoogle Scholar
• Castro-Borges W, Dowle A, Curwen RS, et al. Enzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidates. PLoS Negl Trop Dis 2011;5:e993
   PubMed Web of Science ®Google Scholar
• Braschi S, Curwen RS, Ashton PD, et al. The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 2006;6:1471-82
   PubMed Web of Science ®Google Scholar
• Cardoso FC, Macedo GC, Gava E, et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLoS Negl Trop Dis 2008;2:e308
   PubMed Web of Science ®Google Scholar
• Lochmatter C, Schneider CL, Ingram K, et al. Schistosoma mansoni tetraspanning orphan receptor (SmTOR): a new vaccine candidate against schistosomiasis. Clin Exp Immunol 2012;170:342-57
   PubMedGoogle Scholar
• Hota-Mitchell S, Siddiqui AA, Dekaban GA, et al. Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain. Vaccine 1997;15:1631-40
   PubMed Web of Science ®Google Scholar
• Ahmad G, Torben W, Zhang W, et al. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni. Parasite Immunol 2009;31:156-61
   PubMed Web of Science ®Google Scholar
• Zhang W, Ahmad G, Torben W, et al. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. J Infect Dis 2010;201:1105-12
   PubMed Web of Science ®Google Scholar
• Karmakar S, Zhang W, Ahmad G, et al. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Torben W, Ahmad G, Zhang W, Siddiqui AA. Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models. Vaccine 2011;29:2262-71
   PubMedGoogle Scholar
• Karmakar S, Zhang W, Ahmad G, et al. Complement plays a minimal role in Sm-p80-mediated protection against Schistosoma mansoni. Hum Vaccin Immunother 2013. [Epub ahead of print]
   PubMedGoogle Scholar
• Karmakar S, Zhang W, Ahmad G, et al. Therapeutic vaccine: Killing of established adult schistosome parasites in chronically infected baboons following vaccination with Sm-p80 vaccine. J Infect Dis 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Tran MH, Pearson MS, Bethony JM, et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 2006;12:835-40
   PubMed Web of Science ®Google Scholar
• Cupit PM, Steinauer ML, Tonnessen BW, et al. Polymorphism associated with the Schistosoma mansoni tetraspanin-2 gene. Int J Parasitol 2011;41:1249-52
   PubMedGoogle Scholar
• Zhang W, Li J, Duke M, et al. Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target. PLoS Negl Trop Dis 2011;5:e1166
   PubMedGoogle Scholar
• Curti E, Kwityn C, Zhan B, et al. Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein: A vaccine candidate for human intestinal schistosomiasis. Hum Vaccin Immunother 2013. [Epub ahead of print]
   Google Scholar
• McWilliam HEG, Driguez P, Piedrafita D, et al. Novel immunomic technologies for schistosome vaccine development. Parasite Immunol 2012;34:276-84
   PubMed Web of Science ®Google Scholar
• James SL. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvicidal macrophages. J Immunol 1986;136:3872-7
   PubMed Web of Science ®Google Scholar
• James SL, Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol 1989;143:4208-12
   PubMed Web of Science ®Google Scholar
• Anderson S, Shires VL, Wilson RA, Mountford AP. In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics. Eur J Immunol 1998;28:2827-38
   PubMedGoogle Scholar
• Mangold BL, Dean DA. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J Immunol 1986;136:2644-8
   PubMed Web of Science ®Google Scholar
• Williams ME, Caspar P, Oswald I, et al. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-β, which down-regulates macrophage antiparasitic activity. J Immunol 1995;154:4963-700
   Google Scholar
• Wang X, Dong L, Ni H, et al. Combined TLR7/8 and TLR9 ligands potentiate the activity of a Schistosoma japonicum DNA vaccine. PLoS Negl Trop Dis 2013;7:e2164
   PubMedGoogle Scholar
• Wilson MS, Cheever AW, White SD, et al. IL-10 blocks the development of resistance to re-infection with Schistosoma mansoni. PLoS Pathog 2011;7:e1002171
   PubMedGoogle Scholar
• Rickard MD, Williams JF. Hydatidosis/cysticercosis: immune mechanisms and immunization against infection. Adv Parasitol 1982;21:229-96
   PubMed Web of Science ®Google Scholar
• Lightowlers MW. Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. Parasitology 2013;140(13):1566-77
   PubMedGoogle Scholar
• Rickard MD, Bell KJ. Successful vaccination of lambs against infection with Taenia ovis using antigens produced during in vitro cultivation of the larval stages. Res Vet Sci 1971;12:401-12
   PubMed Web of Science ®Google Scholar
• Johnson KS, Harrison GBL, Lightowlers MW, et al. Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature 1989;338:585-7
   PubMed Web of Science ®Google Scholar
• Harrison GB, Heath DD, Dempster RP, et al. Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheres. Int J Parasitol 1996;26:195-204
   PubMed Web of Science ®Google Scholar
• Lightowlers MW. Vaccination against cestode parasites. Int J Parasitol 1996;26:819-24
   PubMedGoogle Scholar
• Gauci CG, Flisser A, Lightowlers MW. A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens. Int J Parasitol 1998;28:757-60
   PubMed Web of Science ®Google Scholar
• Gauci CG, Lightowlers MW. Alternative splicing and sequence diversity of transcripts from the oncosphere stage of Taenia solium with homology to the 45W antigen of Taenia ovis. Mol Biochem Parasitol 2001;112:173-81
   PubMed Web of Science ®Google Scholar
• Gauci CG, Jayashi CM, Gonzalez AE, et al. Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens. Vaccine 2012;30:3824-8
   PubMed Web of Science ®Google Scholar
• Flisser A, Gauci CG, Zoli A, et al. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun 2004;72:5292-7
   PubMed Web of Science ®Google Scholar
• Assana E, Kyngdon CT, Gauci CG, et al. Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol 2010;40:515-19
   PubMed Web of Science ®Google Scholar
• Haag KL, Gottstein B, Ayala FJ. The EG95 antigen of Echinococcus spp. contains positively selected amino acids, which may influence host specificity and vaccine efficacy. PLoS One 2009;4:e5362
   PubMedGoogle Scholar
• Jayashi CM, Kyngdon CT, Gauci CG, et al. Successful immunization of naturally reared pigs against porcine cysticercosis with a recombinant oncosphere antigen vaccine. Vet Parasitol 2012;188:261-7
   PubMed Web of Science ®Google Scholar
• Gauci CG, Ito A, Lightowlers MW. Conservation of the vaccine antigen gene, TSOL18, among genetically variant isolates of Taenia solium. Mol Biochem Parasitol 2006;146:101-4
   PubMedGoogle Scholar
• Zhang W, Ross AG, McManus DP. Mechanisms of immunity in hydatid disease: implications for vaccine development. J Immunol 2008;181:6679-85
   PubMedGoogle Scholar
• Lightowlers MW, Lawrence SB, Gauci CG, et al. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol 1996;18:457-62
   PubMed Web of Science ®Google Scholar
• Jabbar A, Jenkins DJ, Crawford S, et al. Oncospheral penetration glands are the source of the EG95 vaccine antigen against cystic hydatid disease. Parasitology 2011;138:89-99
   PubMedGoogle Scholar
• Gauci C, Merli M, Muller V, et al. Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis. Infect Immun 2002;70:3969-72
   PubMed Web of Science ®Google Scholar
• Heath DD, Robinson C, Shakes T, et al. Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis). Vaccine 2012;30:3076-81
   PubMedGoogle Scholar
• Zhang W, Zhang Z, Shi B, et al. Vaccination of dogs against Echinococcus granulosus, the cause of cystic hydatid disease in humans. J Infect Dis 2006;194:966-74
   PubMedGoogle Scholar
• Jarrett WFH, Jennings FW, McIntyre WIM, et al. Immunological studies on Dictyocaulus viviparus infection in calves - double vaccination with irradiated larvae. Am J Vet Res 1959;20:522-6
   Google Scholar
• Miller TA. Effect of route of administration of vaccine challenge on the immunogenic efficiency of double vaccination with irradiated Ancylostoma caninum larvae. J Parasitol 1965;51:200-6
   PubMedGoogle Scholar
• Miller JE, Horohov DW. Immunological aspects of nematode parasite control in sheep. J Anim Sci 2006;84(Suppl):E124-32
   PubMedGoogle Scholar
• Newton SE, Munn EA. The development of vaccines against gastrointestinal nematode parasites, particularly Haemonchus contortus. Parasitol Today 1999;15:116-22
   PubMedGoogle Scholar
• Smith WD, Angus KW. Haemonchus contortus: attempts to immunise lambs with irradiated larvae. Res Vet Sci 1980;29:45-50
   PubMedGoogle Scholar
• Bethony JM, Loukas A, Hotez PJ, Knox DP. Vaccines against blood-feeding nematodes of humans and livestock. Parasitology 2006;133(Suppl):S63-79
   PubMedGoogle Scholar
• Munn EA, Smith TS, Graham M, et al. Vaccination of merino lambs against haemonchosis with membrane-associated proteins from the adult parasite. Parasitology 1993;106:63-6
   PubMedGoogle Scholar
• Smith TS, Graham M, Munn EA, et al. Cloning and characterization of a microsomal aminopeptidase from the intestine of the nematode Haemonchus contortus. Biochim Biophys Acta 1997;1338:295-306
   PubMed Web of Science ®Google Scholar
• Reszka N, Rijsewijk FA, Zelnik V, et al. Haemonchus contortus: characterization of the baculovirus expressed form of aminopeptidase H11. Exp Parasitol 2007;117:208-13
   PubMedGoogle Scholar
• Smith WD, Smith SK, Murray JM. Protection studies with integral membrane fractions of Haemonchus contortus. Parasite Immunol 1994;16:231-41
   PubMedGoogle Scholar
• Smith SK, Smith WD. Immunisation of sheep with an integral membrane glycoprotein complex of Haemonchus contortus and with its major polypeptide components. Res Vet Sci 1996;60:1-6
   PubMedGoogle Scholar
• Smith SK, Pettit D, Newlands GF, et al. Further immunization and biochemical studies with a protective antigen complex from the microvillar membrane of the intestine of Haemonchus contortus. Parasite Immunol 1999;21:187-99
   PubMed Web of Science ®Google Scholar
• Skuce PJ, Newlands GF, Stewart EM, et al. Cloning and characterisation of thrombospondin, a novel multidomain glycoprotein found in association with a host protective gut extract from Haemonchus contortus. Mol Biochem Parasitol 2001;117:241-4
   PubMedGoogle Scholar
• Smith WD, Newlands GF, Smith SK, et al. Metalloendopeptidases from the intestinal brush border of Haemonchus contortus as protective antigens for sheep. Parasite Immunol 2003;25:313-23
   PubMedGoogle Scholar
• Knox D. Proteases in blood-feeding nematodes and their potential as vaccine candidates. Adv Exp Med Biol 2011;712:155-76
   PubMedGoogle Scholar
• Ellis SE, Newlands GF, Nisbet AJ, Matthews JB. Phage-display library biopanning as a novel approach to identifying nematode vaccine antigens. Parasite Immunol 2012;34:285-95
   PubMedGoogle Scholar
• Knox DP, Redmond DL, Jones DG. Characterization of proteinases in extracts of adult Haemonchus contortus, the ovine abomasal nematode. Parasitology 1993;106(Pt 4):395-404
   PubMedGoogle Scholar
• Knox DP, Smith SK, Smith WD. Immunization with an affinity purified protein extract from the adult parasite protects lambs against infection with Haemonchus contortus. Parasite Immunol 1999;21:201-10
   PubMed Web of Science ®Google Scholar
• Bakker N, Vervelde L, Kanobana K, et al. Vaccination against the nematode Haemonchus contortus with a thiol-binding fraction from the excretory/secretory products (ES). Vaccine 2004;22:618-28
   PubMedGoogle Scholar
• Redmond DL, Knox DP. Protection studies in sheep using affinity-purified and recombinant cysteine proteinases of adult Haemonchus contortus. Vaccine 2004;22:4252-61
   PubMedGoogle Scholar
• Rinaldi M, Geldhof P. Immunologically based control strategies for ostertagiosis in cattle: where do we stand? Parasite Immunol 2012;34:254-64
   PubMedGoogle Scholar
• Geldhof P, Claerebout E, Knox D, et al. Vaccination of calves against Ostertagia ostertagi with cysteine proteinase enriched protein fractions. Parasite Immunol 2002;24:263-70
   PubMed Web of Science ®Google Scholar
• Meyvis Y, Geldhof P, Gevaert K, et al. Vaccination against Ostertagia ostertagi with subfractions of the protective ES-thiol fraction. Vet Parasitol 2007;149:239-45
   PubMedGoogle Scholar
• Van Meulder F, Van Coppernolle S, Borloo J, et al. Granule exocytosis of granulysin and granzyme B as a potential key mechanism in vaccine-induced immunity in cattle against the nematode Ostertagia ostertagi. Infect Immun 2013;81:1798-809
   PubMedGoogle Scholar
• Geldhof P, Meyvis Y, Vercruysse J, Claerebout E. Vaccine testing of a recombinant activation-associated secreted protein (ASP1) from Ostertagia ostertagi. Parasite Immunol 2008;30:57-60
   PubMedGoogle Scholar
• Vercauteren I, Geldhof P, Peelaers I, et al. Identification of excretory-secretory products of larval and adult Ostertagia ostertagi by immunoscreening of cDNA libraries. Mol Biochem Parasitol 2003;126:201-8
   PubMedGoogle Scholar
• Vercauteren I, Geldhof P, Vercruysse J, et al. Vaccination with an Ostertagia ostertagi polyprotein allergen protects calves against homologous challenge infection. Infect Immun 2004;72:2995-3001
   PubMedGoogle Scholar
• Harrison GB, Pulford HD, Doolin EE, et al. Antibodies to surface epitopes of the carbohydrate larval antigen CarLA are associated with passive protection in strongylid nematode challenge infections. Parasite Immunol 2008;30:577-84
   PubMedGoogle Scholar
• Maass DR, Harrison GB, Grant WN, et al. Intraspecific epitopic variation in a carbohydrate antigen exposed on the surface of Trichostrongylus colubriformis infective L3 larvae. PLoS Pathog 2009;5:e1000597
   PubMedGoogle Scholar
• Nisbet AJ, McNeilly TN, Wildblood LA, et al. Successful immunization against a parasitic nematode by vaccination with recombinant proteins. Vaccine 2013;31:4017-23
   PubMed Web of Science ®Google Scholar
• Monahan CM, Taylor HW, Chapman MR, Klei TR. Experimental immunization of ponies with Strongylus vulgaris radiation-attenuated larvae or crude soluble somatic extracts from larval or adult stages. J Parasitol 1994;80:911-23
   PubMedGoogle Scholar
• Urban JF, Tromba FG. An ultraviolet-attenuated egg vaccine for swine ascariasis: parameters affecting the development of protective immunity. Am J Vet Res 1984;45:2104-8
   PubMed Web of Science ®Google Scholar
• Tsuji N, Miyoshi T, Islam MK, et al. Recombinant Ascaris 16-Kilodalton protein-induced protection against Ascaris suum larval migration after intranasal vaccination in pigs. J Infect Dis 2004;190:1812-20
   PubMedGoogle Scholar
• Tsuji N, Suzuki K, Kasuga-Aoki H, et al. Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice. Infect Immun 2001;69:7285-92
   PubMed Web of Science ®Google Scholar
• He G, Chen S, Wang T, et al. Sequence analysis of the Bs-Ag1 gene of Baylisascaris schroederi from the giant panda and an evaluation of the efficacy of a recombinant Baylisascaris schroederi Bs-Ag1 antigen in mice. DNA Cell Biol 2012;31:1174-81
   PubMedGoogle Scholar
• Islam MK, Miyoshi T, Tsuji N. Vaccination with recombinant Ascaris suum 24-kilodalton antigen induces a Th1/Th2-mixed type immune response and confers high levels of protection against challenged Ascaris suum lung-stage infection in BALB/c mice. Int J Parasitol 2005;35:1023-30
   PubMed Web of Science ®Google Scholar
• Zhan B, Beaumier CM, Briggs N, et al. Advancing a multivalent ’Pan-anthelmintic’ vaccine against soil-transmitted nematode infections. Expert Rev Vaccines 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Nicholas WL, Stewart AC, Mitchell GF. Antibody responses to Toxocara canis using sera from parasite-infected mice, and protection from toxocariasis by immunisation with ES antigens. Aust J Exp Biol Med 1984;62:619-26
   PubMedGoogle Scholar
• Mejia JS, Carlow CKS. An analysis of the humoral immune response following vaccination with irradiated infective larvae of Dirofilaria immitis. Parasite Immunol 1994;16:157-64
   PubMed Web of Science ®Google Scholar
• Townson S, Bianco AE. Immunization of calves against the microfilariae of Onchocerca lienalis. J Helminthol 1982;56:297-303
   PubMedGoogle Scholar
• Tchakoute VL, Graham SP, Jensen SA, et al. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination. Proc Natl Acad Sci USA 2006;103:5971-6
   PubMed Web of Science ®Google Scholar
• Acosta D, Cancela M, Piacenza L, et al. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis. Mol Biochem Parasitol 2008;158:52-64
   PubMed Web of Science ®Google Scholar
• Golden O, Flynn RJ, Read C, et al. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine 2010;28:5551-7
   PubMed Web of Science ®Google Scholar
• Hillyer GV. Fasciola antigens as vaccines against fascioliasis and schistosomiasis. J Helminthol 2005;79:241-7
   PubMedGoogle Scholar
• Driguez P, Doolan DL, Loukas A, et al. Schistosomiasis vaccine discovery using immunomics. Parasit Vectors 2010;3:4
   PubMed Web of Science ®Google Scholar
• van Diepen A, Smit CH, van Egmond L, et al. Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray. PLoS Negl Trop Dis 2012;6(11):e1922
   PubMed Web of Science ®Google Scholar
• Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011;12:509-17
   PubMed Web of Science ®Google Scholar
• Brewer JM, Conacher M, Hunter CA, et al. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol 1999;163:6448-54
   PubMed Web of Science ®Google Scholar
• Piedrafita D, Preston S, Kemp J, et al. The effect of different adjuvants on immune parameters and protection following vaccination of sheep with a larval-specific antigen of the gastrointestinal nematode, Haemonchus contortus. PLoS One 2013;8:e78357
   PubMed Web of Science ®Google Scholar
• Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol 2011;11:865-72
   PubMed Web of Science ®Google Scholar
• Koff WC, Burton DR, Johnson PR, et al. Accelerating next-generation vaccine development for global disease prevention. Science 2013;340:1232910
   PubMed Web of Science ®Google Scholar